The_change_in_patterns_of_relapse_in_medulloblastoma._The_authors_reviewed_89_patients_treated_for_cerebellar_medulloblastoma_between_1970_and_1989_to_determine_the_impact_of_changing_treatment_(high-dose_posterior_fossa_radiation_therapy_and_chemotherapy)_on_the_pattern_of_failure_in_medulloblastoma._Between_1970_and_1983,_50_patients_(median_follow-up,_110_months)_were_treated_with_surgery_and_postoperative_craniospinal_irradiation_(CSI)._Nineteen_of_the_50_(38%)_recurred_in_the_central_nervous_system_(CNS)._Isolated_systemic_(bone)_metastases_occurred_in_six._The_median_time_to_the_development_of_bone_metastases_was_12_months._Since_1984,_39_patients_(median_follow-up,_27_months)_were_treated_with_preradiation_chemotherapy_consisting_of_cisplatin_and_vincristine_for_9_weeks_before_initiation_of_CSI._Nine_of_the_39_(23%)_patients_recurred_in_the_CNS._There_were_no_systemic_failures_in_this_cohort._The_actuarial_5-year_disease-free_survival_was_55_+/-_7%_for_the_earlier_cohort_and_72_+/-_8%_for_the_later_cohort_(P_equals_0.3)._Posterior_fossa_recurrence_was_associated_with_radiation_therapy_to_this_area._The_cumulative_incidence_of_posterior_fossa_relapse_was_50_+/-_13%_in_patients_who_received_less_than_5300_cGy_and_18_+/-_7%_in_those_who_received_5300_cGy_or_more_(P_equals_0.005)._All_six_bone_relapses_were_in_patients_treated_with_CSI_alone_and_5300_cGy_or_more_to_the_posterior_fossa_for_a_5-year_cumulative_incidence_of_bone_metastases_of_18_+/-_7%_compared_with_0%_for_patients_treated_with_5300_cGy_or_more_and_chemotherapy_(P_equals_0.03)._The_authors_concluded_that_high-dose_radiation_therapy_has_altered_the_pattern_of_relapse_with_an_increase_in_systemic_recurrence_after_radiation_therapy_alone_that_is_now_equivalent_to_the_risk_of_recurrence_in_the_posterior_fossa._Chemotherapy_may_be_indicated_in_an_attempt_to_decrease_this_high_risk_of_systemic_metastases.